<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:06:42Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9667800" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9667800</identifier>
        <datestamp>2023-11-01</datestamp>
        <setSpec>annalsats</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Ann Am Thorac Soc</journal-id>
              <journal-id journal-id-type="iso-abbrev">Ann Am Thorac Soc</journal-id>
              <journal-id journal-id-type="publisher-id">AnnalsATS</journal-id>
              <journal-title-group>
                <journal-title>Annals of the American Thoracic Society</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">2329-6933</issn>
              <issn pub-type="epub">2325-6621</issn>
              <publisher>
                <publisher-name>American Thoracic Society</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9667800</article-id>
              <article-id pub-id-type="pmcid">PMC9667800</article-id>
              <article-id pub-id-type="pmc-uid">9667800</article-id>
              <article-id pub-id-type="pmid">35914215</article-id>
              <article-id pub-id-type="pmid">35914215</article-id>
              <article-id pub-id-type="publisher-manuscript">202203-214OC</article-id>
              <article-id pub-id-type="doi">10.1513/AnnalsATS.202203-214OC</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group>
                    <subject>Adult Pulmonary</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Promoting Chronic Obstructive Pulmonary Disease Wellness through Remote Monitoring and Health Coaching: A Clinical Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Benzo</surname>
                    <given-names>Roberto</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hoult</surname>
                    <given-names>Johanna</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McEvoy</surname>
                    <given-names>Charlene</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Clark</surname>
                    <given-names>Matthew</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Benzo</surname>
                    <given-names>Maria</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Johnson</surname>
                    <given-names>Margaret</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Novotny</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <aff id="aff1"><label><sup>1</sup></label>Mindful Breathing Laboratory, Division of Pulmonary, Critical Care, and Sleep Medicine,</aff>
                <aff id="aff3"><label><sup>3</sup></label>Department of Psychology, and</aff>
                <aff id="aff5"><label><sup>5</sup></label>Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota;</aff>
                <aff id="aff2"><label><sup>2</sup></label>Health Partners Research Foundation, Saint Paul, Minnesota; and</aff>
                <aff id="aff4"><label><sup>4</sup></label>Division of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Jacksonville, Florida</aff>
              </contrib-group>
              <author-notes>
                <corresp>Correspondence and requests for reprints should be addressed to Roberto Benzo, M.D., M.S., Mindful Breathing Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55902. E-mail: <email xlink:href="mailto:benzo.roberto@mayo.edu">benzo.roberto@mayo.edu</email>.</corresp>
              </author-notes>
              <pub-date date-type="pub" publication-format="electronic">
                <day>1</day>
                <month>11</month>
                <year>2022</year>
              </pub-date>
              <pub-date date-type="collection" publication-format="electronic">
                <day>1</day>
                <month>11</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>1</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <!--PMC Release delay is 12 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>19</volume>
              <issue>11</issue>
              <fpage>1808</fpage>
              <lpage>1817</lpage>
              <history>
                <date date-type="received">
                  <day>10</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>1</day>
                  <month>8</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2022 by the American Thoracic Society</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This article is open access and distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution Non-Commercial No Derivatives License 4.0</ext-link>. For commercial usage and reprints, please e-mail <email xlink:href="mailto:dgern@thoracic.org">Diane Gern</email>.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="AnnalsATS.202203-214OC.pdf"/>
              <related-object object-id="10.1513/AnnalsATS.202203-214OC_discussion" object-id-type="doi" object-type="discussion" id="ro214OC"/>
              <abstract>
                <sec>
                  <title>Rationale</title>
                  <p>Quality of life (QoL) matters the most to patients with chronic obstructive pulmonary disease (COPD) and is associated with healthcare usage and survival. Pulmonary rehabilitation is the most effective intervention in improving QoL but has low uptake and adherence. Home-based programs are a proposed solution. However, there is a knowledge gap on effective and sustainable home-based programs impacting QoL in patients with COPD.</p>
                </sec>
                <sec>
                  <title>Objectives</title>
                  <p>To determine whether remote patient monitoring with health coaching improves the physical and emotional disease-specific QoL measured by the Chronic Respiratory Questionnaire (CRQ).</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>This multicenter clinical trial enrolled 375 adult patients with COPD, randomized to a 12-week remote patient monitoring with health coaching (<italic>n</italic> = 188) or wait-list usual care (<italic>n</italic> = 187). Primary outcomes include physical and emotional QoL measured by the CRQ summary scores. Prespecified secondary outcomes included the CRQ domains: dyspnea, CRQ-fatigue, CRQ-emotions, CRQ-mastery, daily physical activity, self-management abilities, symptoms of depression/anxiety, emergency room/hospital admissions, and sleep.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Participant age: 69 ± 9 years; 59% women; forced expiratory volume in 1 second percent predicted: 45 ± 19. At 12 weeks, there was a significant and clinically meaningful difference between the intervention versus the control group in the physical and emotional CRQ summary scores: change difference (95% confidence interval): 0.54 points (0.36–0.73), <italic>P</italic> &lt; 0.001; 0.51 (0.39–0.69), <italic>P</italic> &lt; 0.001, respectively. In addition, all CRQ domains, self-management, daily physical activity, sleep, and depression scores improved (<italic>P</italic> &lt; 0.01). CRQ changes were maintained at 24 weeks.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>Remote monitoring with health coaching promotes COPD wellness and behavior change, given its effect on all aspects of QoL, self-management, daily physical activity, sleep, and depression scores. It represents an effective option for home-based rehabilitation.</p>
                  <p>Clinical trial registered with <ext-link xlink:href="http://www.clinicaltrials.gov" ext-link-type="uri">clinicaltrials.gov</ext-link> (NCT 03480386).</p>
                </sec>
              </abstract>
              <kwd-group>
                <title>Keywords</title>
                <kwd>COPD</kwd>
                <kwd>rehabilitation</kwd>
                <kwd>quality of life</kwd>
                <kwd>self-management</kwd>
                <kwd>disease management</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group award-type="grant">
                  <funding-source country="US">
                    <institution-wrap>
                      <institution>National Heart Lung and Blood Institute</institution>
                      <institution-id institution-id-type="doi">10.13039/100000050</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="3"/>
                <ref-count count="33"/>
                <page-count count="10"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p content-type="flushleft">Health-related quality of life (QoL) is considered a critical patient-reported outcome in chronic obstructive pulmonary disease (COPD). It is not only what matters the most to the patient but is also associated with other meaningful outcomes, including hospitalizations and survival (<xref rid="bib1" ref-type="bibr">1</xref>–<xref rid="bib3" ref-type="bibr">3</xref>). Because of the increased recognition of patient symptoms and perceptions of health as a key component of the Global Initiative for Chronic Obstructive Lung Disease (GOLD)– COPD assessment and care (<xref rid="bib4" ref-type="bibr">4</xref>), their role in precipitating healthcare events, and the impact on patient lives, feasible and effective interventions that improve symptoms and consequently QoL in COPD are needed for comprehensive care of COPD.</p>
            <p>Pulmonary rehabilitation (PR) is the most effective nonpharmacological therapy to improve the QoL for individuals with COPD. It is recommended by numerous management guidelines on the basis of a strong body of evidence (<xref rid="bib5" ref-type="bibr">5</xref>–<xref rid="bib7" ref-type="bibr">7</xref>). Unfortunately, despite the proven benefits, PR programs have low participant uptake, insufficient attendance, and high drop-out rates (<xref rid="bib8" ref-type="bibr">8</xref>). Barriers to PR participation include transportation, access, symptom severity, acute exacerbations, lack of energy, and disruption of daily routines (<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib9" ref-type="bibr">9</xref>). In addition, the coronavirus disease (COVID-19) pandemic dramatically reduced the average attendance of traditional center-based PR (<xref rid="bib10" ref-type="bibr">10</xref>): new options are needed.</p>
            <p>Recently, the American Thoracic Society (ATS) and the European Respiratory Society (ERS) recommended investigating alternative approaches to PR: home-based rehabilitation has been proposed as an option for delivering PR (<xref rid="bib7" ref-type="bibr">7</xref>). To date, two randomized controlled trials of unsupervised home-based PR in England and Australia have shown a noninferior improvement in QoL when compared with conventional center-based PR in patients with stable moderate-to-severe COPD (<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>).</p>
            <p>Remote patient monitoring (RPM) of physiologic parameters has been proposed as another care option to improve QoL and healthcare usage, but the results of three randomized studies have been disappointing (<xref rid="bib13" ref-type="bibr">13</xref>–<xref rid="bib16" ref-type="bibr">16</xref>).</p>
            <p>Health coaching (HC) based on motivational interviewing has been reported to reduce COPD readmissions and facilitate successful home-based PR programs (<xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib17" ref-type="bibr">17</xref>). We recently reported the results of a randomized study of RPM of individuals’ lifestyle with HC that was feasible, exhibited high uptake and adherence, and was possibly effective for patients in the United States with COPD (<xref rid="bib18" ref-type="bibr">18</xref>).</p>
            <p>In the context of the knowledge gap on home-based programs for COPD to improve QoL and building on our previous results and feedback from patients, we aimed to test the effect of a home-based program of RPM with HC on the physical and emotional quality of life in individuals with stable COPD. Secondarily we aimed to test the impact of RPM with HC on disease-specific measures of breathlessness, fatigue, emotions, mastery, healthcare usage, daily physical activity, self-management, sleep, and symptoms of depression and anxiety.</p>
            <sec sec-type="methods">
              <title>Methods</title>
              <p content-type="flushleft">This study received Mayo Clinic Institutional Review Board approval on January 11, 2018, #17–009449, was initially posted on clinicaltrials.gov as NCT03480386 in March 2018, and the first patient was randomized in January 2019.</p>
              <sec>
                <title>Study Design and Setting</title>
                <p content-type="flushleft">Multisite randomized clinical trial with a wait-list control group. The study took place at Mayo Clinic, Rochester, Minnesota; Mayo Clinic, Jacksonville, Florida; and Health Partners, Minneapolis–Saint Paul, Minnesota.</p>
              </sec>
              <sec>
                <title>Randomization</title>
                <p content-type="flushleft">Participants were randomized in a 1:1 ratio to either study group on the basis of a pregenerated sequence of assignments through a computer-generated permuted block randomization with blocks of size four. Group 1 received the 12-week intervention, and Group 2 had a 12-week usual-care control period. We compassionately offered the intervention to the control group after completing the end-of-the-control period measures. Because of the nature of the intervention, participants and clinicians were not blinded.</p>
              </sec>
              <sec>
                <title>Inclusion Criteria</title>
                <p content-type="flushleft">Participants with a clinical diagnosis of COPD (primary inclusion criteria) confirmed by records, age ⩾40 years, a history of a minimum of 10 pack-years of smoking, and the ability to communicate in English.</p>
              </sec>
              <sec>
                <title>Exclusion Criteria</title>
                <p content-type="flushleft">High likelihood of being lost to follow-up: patients with active chemical dependency or inability to complete measures or follow commands because of neurologic or psychiatric impairment.</p>
              </sec>
              <sec>
                <title>Intervention</title>
                <p content-type="flushleft">The 12-week program included weekly HC calls and a remote monitoring system (<xref rid="fig1" ref-type="fig">Figure 1</xref>) that had a computer tablet (<xref rid="fig1" ref-type="fig">Figures 1</xref> and <xref rid="fig2" ref-type="fig">2</xref>), a Garmin Vivofit activity monitor to use all the time during the 12-week intervention (no charging needed), and an oximeter (Nonin 3150) to use during the daily exercise routine of flexibility and balance loaded in the tablet (<xref rid="fig2" ref-type="fig">Figure 2B</xref>).</p>
                <fig position="float" id="fig1">
                  <label>
Figure 1.
</label>
                  <caption>
                    <p>Remote monitoring with health coaching system. Adapted from Ref. <xref rid="bib18" ref-type="bibr">18</xref>.</p>
                  </caption>
                  <graphic xlink:href="AnnalsATS.202203-214OCf1" position="float"/>
                </fig>
                <fig position="float" id="fig2">
                  <label>
Figure 2.
</label>
                  <caption>
                    <p>(<italic>A</italic>) Home screen depicting “To Do List” and “Message Panel” from the health coach. (<italic>B</italic>) The “Flexibility and Balance Exercise” tab depicting the video library. Participants can choose the flexibility practice seated or standing. (<italic>C</italic>) The “Check-In” tab. Participants are asked to answer four daily questions rating their overall well-being, breathing, degree of energy, and yesterday's progress to the step goal. (<italic>D</italic>) The “My Journey” tab documents the cumulative progress the participant has made in daily steps, minutes of daily practice, and daily tracking of health-related questions (<xref rid="bib18" ref-type="bibr">18</xref>).</p>
                  </caption>
                  <graphic xlink:href="AnnalsATS.202203-214OCf2" position="float"/>
                </fig>
                <p>The computer tablet provided had Wi-Fi (default) or cellular network capabilities (if Wi-Fi was not available) and captured daily steps (<xref rid="fig2" ref-type="fig">Figure 2D</xref>) from the Garmin Vivofit, the self-report of symptoms (<xref rid="fig2" ref-type="fig">Figure 2C</xref>), and could send and receive messages to/from the coach (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). The data gathered on the tablet via Bluetooth (steps, compliance with daily exercises, messages, and symptoms) was transmitted to a server and, ultimately, to an online patient portal to monitor compliance with the rehabilitation routine and daily physical activity (<xref rid="fig3" ref-type="fig">Figures 3A–3D</xref>).</p>
                <fig position="float" id="fig3">
                  <label>
Figure 3.
</label>
                  <caption>
                    <p>(<italic>A</italic>) The “Overview” screen shows an overview of all active participants, including data from the activity monitor, compliance with practice, check-in questions, and any messages. Under the “Activity Monitor” column, a red circle will display if the participant has walked fewer than 1,000 steps. The circle will be black if the participant walked more than 1,000 steps. In the “Flexibility and Balance” column, the circle will be shaded in by the number of minutes of exercises completed. The bottom half of the circle depicts the balance practice, and the top half the flexibility practice. The “Check-In” column depicts red circles if the participant answered “Poor” in any category. (<italic>B</italic>) The “Trend Report” displays participant progress over the 12-week intervention. (<italic>C</italic>) The “Weekly Report” gives a daily recap of participant progress over the previous week. (<italic>D</italic>) The “Daily Report” shows steps by the hour, how the participant answered the check-in questions, the time and length of the exercise, and the oxygen saturation at rest and during the exercise practice.</p>
                  </caption>
                  <graphic xlink:href="AnnalsATS.202203-214OCf3" position="float"/>
                </fig>
                <p>The weekly health coach call aimed to be a behavior change intervention supported by the motivational interviewing and self-efficacy theories (<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref>), including a reflection of daily steps (<xref rid="fig2" ref-type="fig">Figure 2D</xref>), symptoms logged daily in the tablet (<xref rid="fig2" ref-type="fig">Figure 2C</xref>), the compliance and feedback to the flexibility and balance video-guided exercises (<xref rid="fig2" ref-type="fig">Figure 2D</xref>), and the setting of weekly goals.</p>
                <p>Individuals were asked to complete three exercise practices daily, 6 days a week: two walks that lasted 6 minutes inside the home and an upper extremity simple yoga routine that lasted 12 minutes, guided by a recording from the computer tablet (<xref rid="fig2" ref-type="fig">Figure 2B</xref>).</p>
              </sec>
              <sec>
                <title>Health Coaches Training</title>
                <p content-type="flushleft">The training of the nonaccredited health coach was based on motivation interviewing and mindfulness.</p>
                <p>Motivation interviewing is an effective counsellings technique that focuses on a collaborative, person-centered approach to elicit and strengthen motivation for change. The motivation interviewing training of the health coaches consisted of reading the interactive book <italic>Building Motivational Interviewing Skills: A Practitioner Workbook</italic> by David Rosengren, the use of a commercially available virtual reality software for motivation interviewing (Simmersion LLC, Columbia MD), and role-playing. In addition, coaches attended weekly fidelity meetings in which 10% of the coaching calls were randomized and rated by the team and the research psychologist for training purposes.</p>
                <p>The mindfulness training included the practice of silence and deep listening as done in our previous work (<xref rid="bib18" ref-type="bibr">18</xref>). Coaches were trained to choose a conversational mode that promoted empathy (as opposed to cheerleading) and to elicit aspects of the patient's life that provided meaning and purpose. The coach did not have the responsibility of fixing problems but to otherwise empower patients for what is feasible lifestyle goals and to trust the coaching process that aims to create a receptive space for the patient.</p>
                <p>The coaching group, non accredited, included two college graduates, a senior research coordinator with a master's degree in health administration, an international medical graduate, and a nurse.</p>
              </sec>
              <sec>
                <title>Control Group</title>
                <p content-type="flushleft">Individuals in the control group had usual care and received an educational packet of 12 self-management themes for weekly self-study to match the intervention (12 encounters).</p>
              </sec>
              <sec>
                <title>Outcomes</title>
                <p content-type="flushleft">The study's prespecified coprimary outcomes published on clinicaltrials.gov (NCT03480386) were the changes in QoL Physical and Emotional Summary scores of the CRQ from baseline to 3 months as stated in the trial registration. Prespecified secondary outcomes included the Self-Management Ability Scale, Daily Physical Activity (Actigraph GT3X, Pensacola FL), Healthcare Usage, Patient Health Questionnaire PHQ-9, Generalized Anxiety Disorder Two-item, Social Support, and Sleep Quality (<italic>see</italic> online supplement for details).</p>
                <p>This study used two activity monitors: the ActiGraph GTX3, which was worn on the wrist for 1 week all the time before and after the 12-week intervention (gold-standard measure of physical activity and sleep), and the Garmin Vivofit, which was used all the time during the 12-week health coaching intervention (no charging needed).</p>
              </sec>
              <sec>
                <title>Statistical Analysis</title>
                <p content-type="flushleft">Changes from baseline to Month 3 between arms were compared using two-sample, two-sided <italic>t</italic> tests using an α of 2.5% for each primary endpoint. Changes with each subject were calculated as their Month 3 value minus their baseline value. Linear regression models were used to model Month 3 values after adjusting for age, forced expiratory volume in 1 second (FEV<sub>1</sub>), baseline modified Medical Research Council (mMRC) score, and the baseline value of the endpoint.</p>
                <p>Intent-to-treat (ITT) analyses tested success rates between arms using Fisher's exact tests supplemented with logistic regression models that adjusted for differences in age, FEV<sub>1</sub>, baseline mMRC, and whether the subject was using medication for depression or anxiety. For the CRQ scales, success was defined as having an increase from a baseline of at least 0.5 (the minimal clinically important difference -MCID-). If subjects had missing values for an endpoint, they were considered failures (not improved).</p>
              </sec>
              <sec>
                <title>Sample Size</title>
                <p content-type="flushleft">Power calculations were on the basis of two-sample, two-sized <italic>t</italic> tests comparing the two groups at 3 months. A total sample of 196–300 complete participants had 80% power (<italic>n</italic> = 196) or 90% power (<italic>n</italic> = 300) to detect a difference of 0.5 (the minimal clinically important difference) (<xref rid="bib21" ref-type="bibr">21</xref>) in the CRQ Physical Summary Scale (Dyspnea– Fatigue) and Emotional Summary Scale (Emotions–Mastery). We used a standard deviation of 1.2 points on the basis of our preliminary data and α of 0.025 (adjusted for two outcomes using a Bonferroni adjustment).</p>
              </sec>
            </sec>
            <sec sec-type="results">
              <title>Results</title>
              <p content-type="flushleft">The CONSORT diagram in <xref rid="fig4" ref-type="fig">Figure 4</xref> depicts participant recruitment, enrollment, withdrawals, and follow-up. Accrual: this study averaged an accrual rate of 11.4 subjects per month, and 60% of the accrual was during the COVID-19 pandemic (Figure E1 in the online supplement). Because of its home-based nature, the study accrued participants residing in 27 states in the United States (Table E1). The baseline characteristics of the participants were similar among the study groups (<xref rid="tbl1" ref-type="table">Table 1</xref>). There was no difference in age, lung function (FEV<sub>1</sub>%), and respiratory disability measured by the mMRC score between the group analyzed and the group that withdrew from the study from any cause.</p>
              <fig position="float" id="fig4">
                <label>
Figure 4.
</label>
                <caption>
                  <p>CONSORT diagram.</p>
                </caption>
                <graphic xlink:href="AnnalsATS.202203-214OCf4" position="float"/>
              </fig>
              <table-wrap position="float" id="tbl1">
                <label>
Table 1.
</label>
                <caption>
                  <p>Patient demographics</p>
                </caption>
                <!--OASIS TABLE HERE-->
                <table frame="hsides" rules="groups">
                  <colgroup>
                    <col align="left"/>
                    <col align="center"/>
                    <col align="center"/>
                  </colgroup>
                  <thead valign="bottom">
                    <tr>
                      <th align="left"> </th>
                      <th align="center">Control/Wait (<italic>n</italic> = <italic>187</italic>)</th>
                      <th align="center">Intervention Now (<italic>n</italic> = <italic>188</italic>)</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td align="left">Age, mean (SD)</td>
                      <td align="center">68.676 (9.530)</td>
                      <td align="center">69.335 (9.530)</td>
                    </tr>
                    <tr>
                      <td align="left">Female, <italic>n</italic> (%)</td>
                      <td align="center">111 (59.4)</td>
                      <td align="center">101 (53.7)</td>
                    </tr>
                    <tr>
                      <td align="left">BMI, mean (SD)</td>
                      <td align="center">29.129 (7.307)</td>
                      <td align="center">28.561 (7.144)</td>
                    </tr>
                    <tr>
                      <td align="left">FEV<sub>1</sub>%, mean (SD)</td>
                      <td align="center">45.274 (18.870)</td>
                      <td align="center">44.103 (19.000)</td>
                    </tr>
                    <tr>
                      <td align="left">Taking long-acting bronchodilators, <italic>n</italic> (%)</td>
                      <td align="center">144 (79.6)</td>
                      <td align="center">150 (81.1)</td>
                    </tr>
                    <tr>
                      <td align="left">Taking inhaled corticosteroids, <italic>n</italic> (%)</td>
                      <td align="center">165 (91.7)</td>
                      <td align="center">176 (95.1)</td>
                    </tr>
                    <tr>
                      <td align="left">On long-term antibiotics, <italic>n</italic> (%)</td>
                      <td align="center">38 (20.9)</td>
                      <td align="center">49 (26.5)</td>
                    </tr>
                    <tr>
                      <td align="left">On long-term prednisone therapy, <italic>n</italic> (%)</td>
                      <td align="center">34 (18.7)</td>
                      <td align="center">43 (23.2)</td>
                    </tr>
                    <tr>
                      <td align="left">Taking meds for depression or anxiety, <italic>n</italic> (%)</td>
                      <td align="center">75 (41.2)</td>
                      <td align="center">75 (40.5)</td>
                    </tr>
                    <tr>
                      <td align="left">Ethnicity, <italic>n</italic> (%)</td>
                      <td align="center"> </td>
                      <td align="center"> </td>
                    </tr>
                    <tr>
                      <td align="left"> Hispanic or Latino</td>
                      <td align="center">1 (0.5)</td>
                      <td align="center">2 (1.1)</td>
                    </tr>
                    <tr>
                      <td align="left"> Not Hispanic or Latino</td>
                      <td align="center">181 (96.8)</td>
                      <td align="center">181 (96.3)</td>
                    </tr>
                    <tr>
                      <td align="left"> Unknown/not reported</td>
                      <td align="center">5 (2.7)</td>
                      <td align="center">5 (2.7)</td>
                    </tr>
                    <tr>
                      <td align="left">White, <italic>n</italic> (%)</td>
                      <td align="center">180 (96.3)</td>
                      <td align="center">177 (94.1)</td>
                    </tr>
                    <tr>
                      <td align="left">High school or less, <italic>n</italic> (%)</td>
                      <td align="center">67 (40.9)</td>
                      <td align="center">44 (25.7)</td>
                    </tr>
                    <tr>
                      <td align="left">Married, <italic>n</italic> (%)</td>
                      <td align="center">102 (60.4)</td>
                      <td align="center">102 (58.6)</td>
                    </tr>
                    <tr>
                      <td align="left">Income ⩽$30,000, <italic>n</italic> (%)</td>
                      <td align="center">55 (33.7)</td>
                      <td align="center">50 (30.1)</td>
                    </tr>
                    <tr>
                      <td align="left">Current smokers, <italic>n</italic> (%)</td>
                      <td align="center">12 (7.3)</td>
                      <td align="center">15 (8.7)</td>
                    </tr>
                    <tr>
                      <td align="left">Uses oxygen for sleep or activity, <italic>n</italic> (%)</td>
                      <td align="center">53 (32.3)</td>
                      <td align="center">48 (28.1)</td>
                    </tr>
                    <tr>
                      <td align="left">Living alone, <italic>n</italic> (%)</td>
                      <td align="center">53 (32.5)</td>
                      <td align="center">54 (31.6)</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="TF1">
                    <p><italic>Definition of abbreviations</italic>: BMI = body mass index; FEV<sub>1</sub>% = volume of air the subject can exhale in 1 second divided by the expected “normal” volume; SD = standard deviation.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>A total of 375 patients were included in the final analysis. All 375 randomized subjects were included in the ITT analyses. The 23% overall withdrawal rate was similar in both arms. The missing data was very low at less than 10% in all the primary and secondary outcomes, with no differences between groups.</p>
              <sec>
                <title>Primary Outcomes: Effect on CRQ Physical and Emotional Summary Scores (<xref rid="tbl2" ref-type="table">Table 2</xref>)</title>
                <p content-type="flushleft">The intervention group showed a statistically and clinically significant difference in the two coprimary outcomes, the CRQ Physical and Emotional summary scores at 12 weeks (<xref rid="tbl2" ref-type="table">Table 2</xref>), and between the intervention and control groups beyond the minimal clinically important difference for CRQ (0.5 points). There was also a significant difference in all the CRQ individual domains: dyspnea, fatigue, emotions, and mastery of dealing with COPD, all favoring the intervention group.</p>
                <table-wrap position="float" id="tbl2">
                  <label>
Table 2.
</label>
                  <caption>
                    <p>Primary outcomes</p>
                  </caption>
                  <!--OASIS TABLE HERE-->
                  <table frame="hsides" rules="groups">
                    <colgroup>
                      <col align="left"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                    </colgroup>
                    <thead valign="bottom">
                      <tr>
                        <th align="left"> </th>
                        <th colspan="3" align="center">Intervention (<italic>n</italic> = <italic>187</italic>)<hr/></th>
                        <th colspan="3" align="center">Usual Care (<italic>n</italic> = <italic>188</italic>)<hr/></th>
                        <th align="center"> </th>
                        <th align="center"> </th>
                      </tr>
                      <tr>
                        <th align="left"> </th>
                        <th colspan="3" align="center">Mean (SD) Score<hr/></th>
                        <th colspan="3" align="center">Mean (SD) Score<hr/></th>
                        <th align="center"> </th>
                        <th align="center"> </th>
                      </tr>
                      <tr>
                        <th align="left">Measure</th>
                        <th align="center">Baseline</th>
                        <th align="center">At 3 mo</th>
                        <th align="center">Change in Score, Mean (95% CI)</th>
                        <th align="center">Baseline</th>
                        <th align="center">At 3 mo</th>
                        <th align="center">Change in Score, Mean (95% CI)</th>
                        <th align="center">Difference, Mean Change (95% CI)</th>
                        <th align="center"><italic>P</italic> Value</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td align="left">Coprimary outcome</td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                      </tr>
                      <tr>
                        <td align="left"> CRQ physical</td>
                        <td align="center">3.8 (1.18)</td>
                        <td align="center">4.35 (1.14)</td>
                        <td align="center">0.37 (0.24 to 0.51)</td>
                        <td align="center">3.94 (1.13)</td>
                        <td align="center">3.81 (1.2)</td>
                        <td align="center">−0.17 (−0.29 to 0.05)</td>
                        <td align="center">0.54 (0.36 to 0.73)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left"> CRQ emotional</td>
                        <td align="center">4.48 (1.18)</td>
                        <td align="center">5.02 (1.01)</td>
                        <td align="center">0.43 (0.29 to 0.57)</td>
                        <td align="center">4.5 (1.19)</td>
                        <td align="center">4.48 (1.21)</td>
                        <td align="center">−0.08 (−0.2 to 0.05)</td>
                        <td align="center">0.51 (0.31 to 0.7)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left">Secondary outcome</td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                        <td align="center"> </td>
                      </tr>
                      <tr>
                        <td align="left"> CRQ dyspnea</td>
                        <td align="center">4.01 (1.42)</td>
                        <td align="center">4.54 (1.41)</td>
                        <td align="center">0.37 (0.21 to 0.53)</td>
                        <td align="center">4.21 (1.42)</td>
                        <td align="center">4.01 (1.48)</td>
                        <td align="center">−0.2 (−0.34 to −0.05)</td>
                        <td align="center">0.57 (0.35 to 0.78)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left"> CRQ fatigue</td>
                        <td align="center">3.57 (1.2)</td>
                        <td align="center">4.13 (1.18)</td>
                        <td align="center">0.39 (0.22 to 0.55)</td>
                        <td align="center">3.62 (1.18)</td>
                        <td align="center">3.57 (1.2)</td>
                        <td align="center">−0.13 (−0.27 to 0.01)</td>
                        <td align="center">0.52 (0.3 to 0.74)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left"> CRQ emotions</td>
                        <td align="center">4.55 (1.17)</td>
                        <td align="center">5.05 (1.01)</td>
                        <td align="center">0.39 (0.24 to 0.54)</td>
                        <td align="center">4.57 (1.19)</td>
                        <td align="center">4.55 (1.21)</td>
                        <td align="center">−0.08 (−0.21 to 0.05)</td>
                        <td align="center">0.47 (0.27 to 0.66)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left"> CRQ mastery</td>
                        <td align="center">4.35 (1.41)</td>
                        <td align="center">4.96 (1.29)</td>
                        <td align="center">0.5 (0.33 to 0.67)</td>
                        <td align="center">4.38 (1.4)</td>
                        <td align="center">4.35 (1.41)</td>
                        <td align="center">−0.07 (−0.25 to 0.11)</td>
                        <td align="center">0.57 (0.32 to 0.82)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="TF2">
                      <p><italic>Definition of abbreviations</italic>: CI = confidence interval; CRQ = Chronic Respiratory Questionnaire; mo = months; SD = standard deviation.</p>
                    </fn>
                    <fn id="TF3">
                      <p>Within-group change in the intervention group at 3 mo. Difference between intervention and control groups at 3 mo.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec>
                <title>Linear Regression Models for Month 3 Values (Table E2)</title>
                <p content-type="flushleft">Linear regression models were used to model Month 3 values after adjusting for age, FEV<sub>1</sub>, baseline mMRC, and the baseline value of the endpoint. The intervention was significantly associated with improvements on all CRQ subscales, after adjusting for confounding factors. There were also significant independent associations between the intervention and several secondary outcomes: PHQ-9, mMRC, self-management [Self-Management Abilities Scale (SMAS) total], sleep [Pittsburgh Sleep Quality Index (PSQI) total], daily steps, total minutes in bed, and total sleep time.</p>
                <p>The effect sizes for almost all the CRQ subscales are above the MCID of 0.5 points. The intervention was also associated with 670 more daily steps at month 3 (<xref rid="bib22" ref-type="bibr">22</xref>).</p>
              </sec>
              <sec>
                <title>The Trajectory of Improvement in the QoL Outcomes</title>
                <p content-type="flushleft">The significant changes from baseline in CRQ at Week 12 were sustained until Week 24 in the Physical and Emotional Summary scores (primary outcomes) (<xref rid="fig5" ref-type="fig">Figure 5</xref>) as well as all the individual CRQ domains (dyspnea, fatigue, emotions, and mastery) (Figure E2). The control group did not improve in the initial 12 weeks (<xref rid="tbl2" ref-type="table">Table 2</xref>) and then meaningfully improved after receiving the intervention (<xref rid="fig5" ref-type="fig">Figures 5</xref> and E2).</p>
                <fig position="float" id="fig5">
                  <label>
Figure 5.
</label>
                  <caption>
                    <p>The trajectory of quality of life in the intervention and control groups. CRQ = Chronic Respiratory Questionnaire.</p>
                  </caption>
                  <graphic xlink:href="AnnalsATS.202203-214OCf5" position="float"/>
                </fig>
              </sec>
              <sec>
                <title>ITT Analyses (Table E3)</title>
                <p content-type="flushleft">For ITT analyses, subjects with missing values were classified as not having improved. In ITT analyses, intervention subjects improved significantly more on the primary outcomes and all the CRQ individual domains. For example, 35% of intervention subjects improved by at least 0.5 points, the minimal clinically important difference
(MCID) on the CRQ Physical Subscale compared with only 12% of control subjects (<italic>P</italic> &lt; 0.0001), and 32% of intervention subjects improved by at least 0.5 points on the CRQ Emotional Summary score compared with 17% of control subjects (<italic>P</italic> &lt; 0.0001).</p>
              </sec>
              <sec>
                <title>The Number Needed to Treat</title>
                <p content-type="flushleft">On the basis of the conservative ITT analysis, four and six patients are required to be treated to meaningfully improve by one in the CRQ Physical Summary Score (Dyspnea–Fatigue) and the Emotional Summary Score (Emotion–Mastery).</p>
              </sec>
              <sec>
                <title>Secondary Outcomes (<xref rid="tbl3" ref-type="table">Table 3</xref>)</title>
                <p content-type="flushleft">Participants in the intervention group demonstrated significantly greater improvements in each of the following outcomes between baseline and 3 months: the mMRC dyspnea score, SMAS total score, the daily steps measured by Actigraph, the PSQI total score, and the PHQ-9 (<xref rid="tbl3" ref-type="table">Table 3</xref>).</p>
                <table-wrap position="float" id="tbl3">
                  <label>
Table 3.
</label>
                  <caption>
                    <p>Other secondary outcomes</p>
                  </caption>
                  <!--OASIS TABLE HERE-->
                  <table frame="hsides" rules="groups">
                    <colgroup>
                      <col align="left"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                      <col align="center"/>
                    </colgroup>
                    <thead valign="bottom">
                      <tr>
                        <th align="left"> </th>
                        <th colspan="3" align="center">Intervention<hr/></th>
                        <th colspan="3" align="center">Usual Care<hr/></th>
                        <th align="center"> </th>
                        <th align="center"> </th>
                      </tr>
                      <tr>
                        <th align="left"> </th>
                        <th colspan="3" align="center">Mean (SD) Score<hr/></th>
                        <th colspan="3" align="center">Mean (SD) Score<hr/></th>
                        <th align="center"> </th>
                        <th align="center"> </th>
                      </tr>
                      <tr>
                        <th align="left">Measure</th>
                        <th align="center">Baseline</th>
                        <th align="center">At 3 months</th>
                        <th align="center">Change in Score, Mean (95% CI)</th>
                        <th align="center">Baseline</th>
                        <th align="center">At 3 months</th>
                        <th align="center">Change in Score, Mean (95% CI)</th>
                        <th align="center">Difference, Mean Change (95% CI)</th>
                        <th align="center"><italic>P</italic> Value</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td align="left">mMRC</td>
                        <td align="center">2.74 (0.82)</td>
                        <td align="center">2.49 (0.97)</td>
                        <td align="center">−0.18 (−0.3 to −0.07)</td>
                        <td align="center">2.64 (0.86)</td>
                        <td align="center">2.74 (0.8)</td>
                        <td align="center">0.12 (0.01 to 0.23)</td>
                        <td align="center">−0.3 (−0.46 to −0.14)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left">SMAS-30,<break/>total score</td>
                        <td align="center">64.69 (12.87)</td>
                        <td align="center">69.1 (12.22)</td>
                        <td align="center">3.84 (2.44 to 5.24)</td>
                        <td align="center">64.19 (12.69)</td>
                        <td align="center">65.2 (12.66)</td>
                        <td align="center">0.54 (−0.62 to 1.71)</td>
                        <td align="center">3.3 (1.48 to 5.11)</td>
                        <td align="center">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left">PSQI,<break/>total score</td>
                        <td align="center">9.39 (3.58)</td>
                        <td align="center">8.48 (3.26)</td>
                        <td align="center">−0.72 (−1.09 to −0.34)</td>
                        <td align="center">9.33 (3.52)</td>
                        <td align="center">9.13 (3.61)</td>
                        <td align="center">0.03 (−0.36 to 0.42)</td>
                        <td align="center">−0.75 (−1.28 to −0.21)</td>
                        <td align="center">0.0068</td>
                      </tr>
                      <tr>
                        <td align="left">PHQ-9,<break/>score</td>
                        <td align="center">6.11 (4.8)</td>
                        <td align="center">4.48 (4.12)</td>
                        <td align="center">−1.12 (−1.67 to −0.58)</td>
                        <td align="center">6.02 (5.44)</td>
                        <td align="center">5.7 (5.02)</td>
                        <td align="center">0.08 (−0.46 to 0.62)</td>
                        <td align="center">−1.2 (−1.97 to −0.44)</td>
                        <td align="center">0.0021</td>
                      </tr>
                      <tr>
                        <td align="left">GAD2, score</td>
                        <td align="center">1.58 (1.75)</td>
                        <td align="center">1.06 (1.38)</td>
                        <td align="center">−0.42 (−0.68 to −0.15)</td>
                        <td align="center">1.48 (1.76)</td>
                        <td align="center">1.2 (1.38)</td>
                        <td align="center">−0.18 (−0.38 to 0.03)</td>
                        <td align="center">−0.24 (−0.57 to 0.09)</td>
                        <td align="center">0.1548</td>
                      </tr>
                      <tr>
                        <td align="left">Mean daily<break/>steps<xref rid="TF6" ref-type="table-fn">*</xref></td>
                        <td align="center">7,148.66 (3,108.48)</td>
                        <td align="center">7,796.09 (3,337.53)</td>
                        <td align="center">478.63 (108.02 to 849.25)</td>
                        <td align="center">7,117.01 (3,212.03)</td>
                        <td align="center">7,047.49 (3,248.72)</td>
                        <td align="center">−146.53 (−458.5 to 165.44)</td>
                        <td align="center">625.16 (142.89 to 1,107.43)</td>
                        <td align="center">0.0113</td>
                      </tr>
                      <tr>
                        <td align="left">Mean daily light physical activity, min<xref rid="TF6" ref-type="table-fn">*</xref></td>
                        <td align="center">493.35 (116.38)</td>
                        <td align="center">516.75 (110.1)</td>
                        <td align="center">17.51 (4.54 to 30.49)</td>
                        <td align="center">493.98 (101.73)</td>
                        <td align="center">492.49 (115.33)</td>
                        <td align="center">0.6 (−13.22 to 14.42)</td>
                        <td align="center">16.91 (−1.96 to 35.78)</td>
                        <td align="center">0.0788</td>
                      </tr>
                      <tr>
                        <td align="left">Mean daily moderate physical activity, min<xref rid="TF6" ref-type="table-fn">*</xref></td>
                        <td align="center">82.63 (61.7)</td>
                        <td align="center">88.85 (62.06)</td>
                        <td align="center">4.47 (−3.17 to 12.11)</td>
                        <td align="center">85.77 (71.26)</td>
                        <td align="center">82.86 (71.5)</td>
                        <td align="center">−4.82 (−11.66 to 2.01)</td>
                        <td align="center">9.29 (−0.91 to 19.5)</td>
                        <td align="center">0.0742</td>
                      </tr>
                      <tr>
                        <td align="left">Total sleep<break/>time, min<xref rid="TF6" ref-type="table-fn">*</xref></td>
                        <td align="center">386.16 (114.21)</td>
                        <td align="center">400.06 (134.8)</td>
                        <td align="center">10.57 (−15.57 to 36.7)</td>
                        <td align="center">410.73 (127.69)</td>
                        <td align="center">397.56 (122.74)</td>
                        <td align="center">−19.2 (−45.21 to 6.81)</td>
                        <td align="center">29.77 (−6.9 to 66.43)</td>
                        <td align="center">0.1125</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="TF4">
                      <p><italic>Definition of abbreviations</italic>: CI = confidence interval; GAD2 = Generalized Anxiety Disorder Two-Item Questionnaire; mMRC = Modified Medical Research Council Dyspnea Scale; PHQ = Patient Health Questionnaire; PSQI = Pittsburgh Sleep Quality Index; SD = standard deviation; SMAS = Self-Management Abilities Scale.</p>
                    </fn>
                    <fn id="TF5">
                      <p>Within-group change in the intervention group at 3 mo. Difference between intervention and control groups at 3 months.</p>
                    </fn>
                    <fn id="TF6">
                      <label>*</label>
                      <p>Measured by Actigraph wGT3X-BT wore for 7 days continuously.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec>
                <title>Healthcare Usage from Baseline to Month 3</title>
                <p content-type="flushleft">Intervention subjects were less likely to have an emergency room visit during the 3-month intervention than the control group: 8.8% versus 16.9%, respectively; <italic>P</italic> = 0.052. There was no difference in hospitalizations (Table E5).</p>
              </sec>
              <sec>
                <title>Predictors of Response and Withdrawal (Table E4)</title>
                <p content-type="flushleft">Logistic models were used to find predictors of response and withdrawal. These models included arm, age, FEV<sub>1</sub>, mMRC, body mass index, and anxiety/depression medication use. Being on the intervention arm was the best predictor of response for almost all the study primary and secondary QoL endpoints. In addition, patients with higher baseline mMRC (worse) were more likely to respond to the CRQ emotion domain. The only predictor of withdrawal in the study was whether the patient was taking depression or anxiety medications at baseline; patients were about twice as likely to withdraw if they took anxiety/depression medications.</p>
              </sec>
              <sec>
                <title>HC Calls and the Working Alliance Inventory</title>
                <p content-type="flushleft">Subjects on the intervention arm had a median of 8 calls (out of 12 possible) with an average call length of 17 minutes. The Working Alliance Inventory total score was 74.9 points, or 90% of the maximal score, indicating a high therapeutic alliance between the health coach and the patient. Compliance with the six-times a week lower-extremity balance practice, upper-extremity flexibility practice, and reporting of symptoms and daily steps was 72%, 74%, and 76%, respectively.</p>
              </sec>
              <sec>
                <title>Safety</title>
                <p content-type="flushleft">No adverse events were reported in the more than 6,000 unsupervised balance and flexibility practices recorded.</p>
              </sec>
            </sec>
            <sec sec-type="discussion">
              <title>Discussion</title>
              <p content-type="flushleft">We found that RPM with HC produces a significant and clinically meaningful improvement in the disease-specific physical and emotional QoL in patients with moderate to severe COPD. This study is the first study of RPM in COPD that improves QoL: three previous RPM studies have been ineffective in improving QoL or healthcare usage (<xref rid="bib13" ref-type="bibr">13</xref>–<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib23" ref-type="bibr">23</xref>).</p>
              <p>The differences between this RPM intervention and the ones tested in previous studies are <italic>1</italic>) the focus on monitoring lifestyle behaviors (daily steps and exercise practice) and symptoms instead of physiologic parameters; and <italic>2</italic>) the emphasis on patient engagement and behavior change through weekly HC (previous studies have only on-demand contact with providers).</p>
              <p>The linear models adjusting for age, FEV<sub>1</sub>, baseline mMRC, and the baseline value of the endpoint being modeled, further confirmed the findings of the comparison between arms, showing the intervention as the sole predictor of the primary outcomes with estimates beyond the MCID and R Squares that are considered very high for social science models (Table E2). After receiving the intervention, the significant improvement of the wait–control group further confirms the intervention's effectiveness (<xref rid="fig5" ref-type="fig">Figures 5</xref> and E2).</p>
              <p>We found that unsupervised home rehabilitation with technology monitoring and HC resulted in improvement in daily physical activity measured by a validated activity monitor expressed in daily steps. This is the first randomized study of unsupervised home rehabilitation for patients with COPD demonstrating clinically meaningful improvement in daily physical activity. Our results provide hope in the “how” of improving physical activity, a marker of overall wellness and better survival in COPD, which is still a challenge in the field (<xref rid="bib24" ref-type="bibr">24</xref>–<xref rid="bib26" ref-type="bibr">26</xref>).</p>
              <p>The observed improvement in daily steps, self-management abilities, depression, and sleep scores, in addition to the perceived improvement in dyspnea, fatigue, emotions, and mastery to live with COPD, plus the maintenance of the benefit after the intervention (<xref rid="fig5" ref-type="fig">Figure 5</xref>), strongly suggest a behavior change in the patient. We confirmed our hypothesis that giving patients the option and the responsibility to set personal goals and make their plans will influence self-management, facilitate and stimulate behavioral change, and eventually lead to improved outcomes. Changing lifestyle through behavior change in a COPD home-based program is a novel aspect of this study.</p>
              <p>We speculate that the HC, on the basis of motivational interviewing and mindfulness, may have been a key factor in behavior change. In addition, HC has been demonstrated to be feasible and effective, with reported decreases in COPD readmissions and a sustainable improvement in quality of life and self-management (<xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib27" ref-type="bibr">27</xref>). We promoted mindfulness in the health coach by practicing silence and deep listening, and in the patient through the practice of awareness of the body and movement during the daily practices of slow walks and standing or sitting simple yoga and also through heightened awareness of daily life events, including emotions.</p>
              <p>This intervention did not have a predefined exercise prescription, as physical activity goals set with the coaches depended on the patient's motivations and mastery. Because of that, this intervention may not fulfill the complete criteria for the definition of conventional PR (<xref rid="bib6" ref-type="bibr">6</xref>). However, we were guided by the World Health Organization (WHO) definition of “rehabilitation”: a set of interventions designed to optimize functioning and reduce disability in individuals with health conditions in interaction with their environment (<xref rid="bib28" ref-type="bibr">28</xref>). The improvement in all domains of QoL, in the mMRC score, a measure of disability in COPD (<xref rid="bib29" ref-type="bibr">29</xref>), depression scores, and self-management very likely accomplished the goal of rehabilitation as defined by the WHO. We aimed for a safe rehabilitation protocol at home and intentionally targeted a lifestyle change. Despite the differences, our findings align with the results of two other randomized studies (<xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>) on unsupervised home-based PR to improve quality of life.</p>
              <p>We believe a potential reduction in emergency room visits associated with the intervention deserves further exploration. We did reach a statistical improvement in daily physical activity measured by a validated activity monitor: this is a major accomplishment since improving physical activity in COPD remains a challenge as no intervention to date has consistently improved this outcome. Interestingly, we observed a more pronounced decrease in physical activity over time in the control: A decline in physical activity during a study period in the control group was similarly observed in our previous randomized study (<xref rid="bib18" ref-type="bibr">18</xref>) and another group (<xref rid="bib21" ref-type="bibr">21</xref>).</p>
              <p>The implementation of a feasible and effective remote rehabilitation for COPD is an important challenge to conquer, even more now because of the need for remote programs in the context of the COVID-19 pandemic.</p>
              <sec>
                <title>This intervention has a high likelihood of implementation</title>
                <p content-type="flushleft">Following the Reach, Effectiveness, Adoption, Implementation, and Maintenance (REAIM)S framework (<xref rid="bib30" ref-type="bibr">30</xref>), we believe that this intervention <bold>R</bold>eached the target population (<xref rid="fig4" ref-type="fig">Figure 4</xref>), is <bold>E</bold>ffective in improving QoL and physical activity, and was the only significant factor associated with the completeness of the 12-week program after adjusting for age, FEV<sub>1</sub>%, and mMRC (Table E4). Furthermore, it is <bold>A</bold>cceptable: 72% of the participants were electronically documented with a six-times a week exercise practice which is novel in the field. RPM with HC can be implemented in any PR center that contracts an RPM service and can use respiratory therapists or nurses as coaches. Regarding <bold>M</bold>aintenance and <bold>S</bold>ustainability: RPM with HC as tested is fully compliant with remote patient monitoring Current Procedural Terminology (CPT) codes (99453–4 and 99457–8) and Remote Therapeutic Monitoring/Treatment Management codes (98975, 98976, 98977, 98980, and 98981), making this intervention sustainable.</p>
              </sec>
              <sec>
                <title>Strengths and Limitations</title>
                <p content-type="flushleft">The strengths of this study beyond its effectiveness results include its methodology, an adequate sample size to test <italic>a priori</italic> hypothesis, ITT analysis, multicentered design, theory-based intervention, the compliance with the intervention, high completion rate of the study outcomes, and data completeness. The conservative ITT analysis (Table E3) confirmed the clinically meaningful benefit of the intervention. It provided estimates of clinically meaningful improvement and a very low number needed to treat for an intervention that seems feasible, effective, and sustainable. Only four patients need to be treated for one that has a clinically meaningful benefit in breathlessness–fatigue (most common symptoms in COPD) and six to meaningfully improve the domain of emotion–mastery.</p>
                <p>We found a range of improvement of QoL beyond the MCID after the intervention that ranged from 32% to 43%, which may seem low, but is comparable to the 44.5% of subjects that improved at least four points on the Saint George Respiratory Questionnaire total at 12 weeks on the National Emphysema Treatment Trial (44.5%) after receiving state-of-the-art PR in the most reputable centers in the United States (<xref rid="bib31" ref-type="bibr">31</xref>).</p>
                <p>Our finding of improving emotional distress (depression) with this feasible intervention merits further exploration given the scarcity of treatments for the prevalent depressive symptoms of COPD.</p>
                <p>This study has several limitations. We cannot define the relative effectiveness of the various components of the intervention: RPM versus HC. In addition, our recruitment was mainly in Whites, limiting the translation of the findings to other ethnic groups. However, the fact that we recruited 30% of patients that were of low income (less than $30,000 yearly in the household) (<xref rid="fig1" ref-type="fig">Figure 1</xref>) and rural participants, well-defined factors for poor adherence to interventions is an asset to this study's generalizability (<xref rid="bib32" ref-type="bibr">32</xref>). Our results do not address the comparative effectiveness of the intervention beyond 12 weeks. Finally, we did not measure exercise capacity, an important outcome in PR, as all measures were done remotely (questionnaires and the ActiGraph were sent by mail: a fully home-base study).</p>
              </sec>
              <sec sec-type="conclusions">
                <title>Conclusions</title>
                <p content-type="flushleft">This unsupervised form of home rehabilitation effectively improves what the patients want most: the quality of their life and perceived function as they live with COPD. In addition, RPM with HC represents a sustainable alternative for individuals that cannot attend conventional PR or prefer a home intervention focused on lifestyle and behavior change.</p>
                <p>HC with lifestyle monitoring aimed to promote wellness, defined by the WHO as an active process of becoming aware of and making choices toward a fulfilling life and a state of balance and not merely the absence of disease (<xref rid="bib33" ref-type="bibr">33</xref>).</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <sec>
                <title>Acknowledgment</title>
                <p>The authors thank Nyanjok Lam, Benjamin Thomas, and Allison Spradley for their work as health coaches and coordinators; Madison Roy for assistance with the statistical analysis; and Kevin Kramer, Ph.D., for his technical assistance.</p>
              </sec>
            </ack>
            <fn-group>
              <fn fn-type="supported-by">
                <p>Supported by grant <award-id>R01 HL140486-4</award-id> from the <funding-source>National Heart Lung and Blood Institute, the National Institutes of Health</funding-source> (R.B. is Principal Investigator). The grant supported all authors.</p>
              </fn>
              <fn>
                <p>Author Contributions: R.B. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: R.B. and P.N. Data acquisition, analysis, and interpretation: R.B., J.H., P.N., C.M., M.C., and M.B. Drafting of the manuscript: R.B., P.N., M.C., M.J., and C.M. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: P.N. and R.B.</p>
              </fn>
              <fn>
                <p>This article has an online supplement, which is accessible from this issue’s table of contents at <ext-link xlink:href="http://www.atsjournals.org" ext-link-type="uri">www.atsjournals.org</ext-link>.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p><underline><bold><ext-link xlink:href="http://www.atsjournals.org/doi/suppl/10.1513/AnnalsATS.202203-214OC/suppl_file/disclosures.pdf" ext-link-type="uri">Author disclosures</ext-link></bold></underline> are available with the text of this article at <ext-link xlink:href="http://www.atsjournals.org" ext-link-type="uri">www.atsjournals.org</ext-link>.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="bib1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fan</surname>
                      <given-names>VS</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Tu</surname>
                      <given-names>SP</given-names>
                    </name>
                    <name>
                      <surname>McDonell</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Fihn</surname>
                      <given-names>SD</given-names>
                    </name>
                    <collab>Ambulatory Care Quality Improvement Project Investigators</collab>
                  </person-group>
                  <article-title>Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases</article-title>
                  <source>
                    <italic>Chest</italic>
                  </source>
                  <year>2002</year>
                  <volume>122</volume>
                  <fpage>429</fpage>
                  <lpage>436</lpage>
                  <pub-id pub-id-type="pmid">12171813</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Domingo-Salvany</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lamarca</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Ferrer</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Garcia-Aymerich</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Alonso</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Félez</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease</article-title>
                  <source>
                    <italic>Am J Respir Crit Care Med</italic>
                  </source>
                  <year>2002</year>
                  <volume>166</volume>
                  <fpage>680</fpage>
                  <lpage>685</lpage>
                  <pub-id pub-id-type="pmid">12204865</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Esteban</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Arostegui</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Aramburu</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Moraza</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Aburto</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Aizpiri</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Changes in health-related quality of life as a marker in the prognosis in COPD patients</article-title>
                  <source>
                    <italic>ERJ Open Res</italic>
                  </source>
                  <year>2022</year>
                  <volume>8</volume>
                  <fpage>00181-2021</fpage>
                  <pub-id pub-id-type="pmid">35036422</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Halpin</surname>
                      <given-names>DMG</given-names>
                    </name>
                    <name>
                      <surname>Criner</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Papi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Anzueto</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>FJ</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science Committee Report on COVID-19 and chronic obstructive pulmonary disease</article-title>
                  <source>
                    <italic>Am J Respir Crit Care Med</italic>
                  </source>
                  <year>2021</year>
                  <volume>203</volume>
                  <fpage>24</fpage>
                  <lpage>36</lpage>
                  <pub-id pub-id-type="pmid">33146552</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Garvey</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bayles</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Hamm</surname>
                      <given-names>LF</given-names>
                    </name>
                    <name>
                      <surname>Hill</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Holland</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Limberg</surname>
                      <given-names>TM</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American Association of Cardiovascular and Pulmonary Rehabilitation</article-title>
                  <source>
                    <italic>J Cardiopulm Rehabil Prev</italic>
                  </source>
                  <year>2016</year>
                  <volume>36</volume>
                  <fpage>75</fpage>
                  <lpage>83</lpage>
                  <pub-id pub-id-type="pmid">26906147</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spruit</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Garvey</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>ZuWallack</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Nici</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Rochester</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                    <collab>ATS/ERS Task Force on Pulmonary Rehabilitation</collab>
                  </person-group>
                  <article-title>An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation</article-title>
                  <source>
                    <italic>Am J Respir Crit Care Med</italic>
                  </source>
                  <year>2013</year>
                  <volume>188</volume>
                  <fpage>e13</fpage>
                  <lpage>e64</lpage>
                  <pub-id pub-id-type="pmid">24127811</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holland</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Houchen-Wolloff</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Rochester</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Garvey</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>ZuWallack</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Defining modern pulmonary rehabilitation. An official American Thoracic Society workshop report</article-title>
                  <source>
                    <italic>Ann Am Thorac Soc</italic>
                  </source>
                  <year>2021</year>
                  <volume>18</volume>
                  <fpage>e12</fpage>
                  <lpage>e29</lpage>
                  <pub-id pub-id-type="pmid">33929307</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Milner</surname>
                      <given-names>SC</given-names>
                    </name>
                    <name>
                      <surname>Boruff</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Beaurepaire</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Janaudis-Ferreira</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Rate of, and barriers and enablers to, pulmonary rehabilitation referral in COPD: a systematic scoping review</article-title>
                  <source>
                    <italic>Respir Med</italic>
                  </source>
                  <year>2018</year>
                  <volume>137</volume>
                  <fpage>103</fpage>
                  <lpage>114</lpage>
                  <pub-id pub-id-type="pmid">29605192</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nici</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Holland</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>ZuWallack</surname>
                      <given-names>RL</given-names>
                    </name>
                  </person-group>
                  <article-title>Opportunities and challenges in expanding pulmonary rehabilitation into the home and community</article-title>
                  <source>
                    <italic>Am J Respir Crit Care Med</italic>
                  </source>
                  <year>2019</year>
                  <volume>200</volume>
                  <fpage>822</fpage>
                  <lpage>827</lpage>
                  <pub-id pub-id-type="pmid">31051091</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tsutsui</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gerayeli</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sin</surname>
                      <given-names>DD</given-names>
                    </name>
                  </person-group>
                  <article-title>Pulmonary rehabilitation in a post-COVID-19 world: telerehabilitation as a new standard in patients with COPD</article-title>
                  <source>
                    <italic>Int J Chron Obstruct Pulmon Dis</italic>
                  </source>
                  <year>2021</year>
                  <volume>16</volume>
                  <fpage>379</fpage>
                  <lpage>391</lpage>
                  <pub-id pub-id-type="pmid">33642858</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horton</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>KE</given-names>
                    </name>
                    <name>
                      <surname>Johnson-Warrington</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Apps</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Sewell</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Morgan</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial</article-title>
                  <source>
                    <italic>Thorax</italic>
                  </source>
                  <year>2018</year>
                  <volume>73</volume>
                  <fpage>29</fpage>
                  <lpage>36</lpage>
                  <pub-id pub-id-type="pmid">28756402</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holland</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Mahal</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hill</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Burge</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>NS</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial</article-title>
                  <source>
                    <italic>Thorax</italic>
                  </source>
                  <year>2017</year>
                  <volume>72</volume>
                  <fpage>57</fpage>
                  <lpage>65</lpage>
                  <pub-id pub-id-type="pmid">27672116</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pinnock</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Hanley</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>McCloughan</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Todd</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Krishan</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial</article-title>
                  <source>
                    <italic>BMJ</italic>
                  </source>
                  <year>2013</year>
                  <volume>347</volume>
                  <fpage>f6070</fpage>
                  <pub-id pub-id-type="pmid">24136634</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Walker</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>Pompilio</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>Zanaboni</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Bergmo</surname>
                      <given-names>TS</given-names>
                    </name>
                    <name>
                      <surname>Prikk</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Malinovschi</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Telemonitoring in chronic obstructive pulmonary disease (CHROMED). A randomized clinical trial</article-title>
                  <source>
                    <italic>Am J Respir Crit Care Med</italic>
                  </source>
                  <year>2018</year>
                  <volume>198</volume>
                  <fpage>620</fpage>
                  <lpage>628</lpage>
                  <pub-id pub-id-type="pmid">29557669</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lilholt</surname>
                      <given-names>PH</given-names>
                    </name>
                    <name>
                      <surname>Witt Udsen</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Ehlers</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Hejlesen</surname>
                      <given-names>OK</given-names>
                    </name>
                  </person-group>
                  <article-title>Telehealthcare for patients suffering from chronic obstructive pulmonary disease: effects on health-related quality of life: results from the Danish ‘TeleCare North’ cluster-randomised trial</article-title>
                  <source>
                    <italic>BMJ Open</italic>
                  </source>
                  <year>2017</year>
                  <volume>7</volume>
                  <fpage>e014587</fpage>
                </mixed-citation>
              </ref>
              <ref id="bib16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chatwin</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hawkins</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Panicchia</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Woods</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hanak</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lucas</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial)</article-title>
                  <source>
                    <italic>Thorax</italic>
                  </source>
                  <year>2016</year>
                  <volume>71</volume>
                  <fpage>305</fpage>
                  <lpage>311</lpage>
                  <pub-id pub-id-type="pmid">26962013</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Benzo</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Vickers</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Novotny</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Tucker</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hoult</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Neuenfeldt</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Health coaching and chronic obstructive pulmonary disease rehospitalization. A randomized study</article-title>
                  <source>
                    <italic>Am J Respir Crit Care Med</italic>
                  </source>
                  <year>2016</year>
                  <volume>194</volume>
                  <fpage>672</fpage>
                  <lpage>680</lpage>
                  <pub-id pub-id-type="pmid">26953637</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Benzo</surname>
                      <given-names>RP</given-names>
                    </name>
                    <name>
                      <surname>Ridgeway</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hoult</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Novotny</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Thomas</surname>
                      <given-names>BE</given-names>
                    </name>
                    <name>
                      <surname>Lam</surname>
                      <given-names>NM</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Feasibility of a health coaching and home-based rehabilitation intervention with remote monitoring for COPD</article-title>
                  <source>
                    <italic>Respir Care</italic>
                  </source>
                  <year>2021</year>
                  <volume>66</volume>
                  <fpage>960</fpage>
                  <lpage>971</lpage>
                  <pub-id pub-id-type="pmid">33906954</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bandura</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Health promotion by social cognitive means</article-title>
                  <source>
                    <italic>Health Educ Behav</italic>
                  </source>
                  <year>2004</year>
                  <volume>31</volume>
                  <fpage>143</fpage>
                  <lpage>164</lpage>
                  <pub-id pub-id-type="pmid">15090118</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moyers</surname>
                      <given-names>TB</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>WR</given-names>
                    </name>
                    <name>
                      <surname>Hendrickson</surname>
                      <given-names>SML</given-names>
                    </name>
                  </person-group>
                  <article-title>How does motivational interviewing work? Therapist interpersonal skill predicts client involvement within motivational interviewing sessions</article-title>
                  <source>
                    <italic>J Consult Clin Psychol</italic>
                  </source>
                  <year>2005</year>
                  <volume>73</volume>
                  <fpage>590</fpage>
                  <lpage>598</lpage>
                  <pub-id pub-id-type="pmid">16173846</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jones</surname>
                      <given-names>PW</given-names>
                    </name>
                    <name>
                      <surname>Beeh</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>KR</given-names>
                    </name>
                    <name>
                      <surname>Decramer</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mahler</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Wedzicha</surname>
                      <given-names>JA</given-names>
                    </name>
                  </person-group>
                  <article-title>Minimal clinically important differences in pharmacological trials</article-title>
                  <source>
                    <italic>Am J Respir Crit Care Med</italic>
                  </source>
                  <year>2014</year>
                  <volume>189</volume>
                  <fpage>250</fpage>
                  <lpage>255</lpage>
                  <pub-id pub-id-type="pmid">24383418</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib22">
                <label>22</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Demeyer</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Burtin</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Hornikx</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Camillo</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Van Remoortel</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Langer</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>The minimal important difference in physical activity in patients with COPD</article-title>
                  <source>
                    <italic>PLoS One</italic>
                  </source>
                  <year>2016</year>
                  <volume>11</volume>
                  <fpage>e0154587</fpage>
                  <pub-id pub-id-type="pmid">27124297</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib23">
                <label>23</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gregersen</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Green</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Frausing</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Ringbaek</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Brøndum</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Suppli Ulrik</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Do telemedical interventions improve quality of life in patients with COPD? A systematic review</article-title>
                  <source>
                    <italic>Int J Chron Obstruct Pulmon Dis</italic>
                  </source>
                  <year>2016</year>
                  <volume>11</volume>
                  <fpage>809</fpage>
                  <lpage>822</lpage>
                  <pub-id pub-id-type="pmid">27143872</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib24">
                <label>24</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shu</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Tsai</surname>
                      <given-names>MK</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>TC</given-names>
                    </name>
                    <name>
                      <surname>Wen</surname>
                      <given-names>CP</given-names>
                    </name>
                  </person-group>
                  <article-title>The ability of physical activity in reducing mortality risks and cardiovascular loading and in extending life expectancy in patients with COPD</article-title>
                  <source>
                    <italic>Sci Rep</italic>
                  </source>
                  <year>2021</year>
                  <volume>11</volume>
                  <fpage>21674</fpage>
                  <pub-id pub-id-type="pmid">34737308</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib25">
                <label>25</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Waschki</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Kirsten</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Holz</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Müller</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Watz</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study</article-title>
                  <source>
                    <italic>Chest</italic>
                  </source>
                  <year>2011</year>
                  <volume>140</volume>
                  <fpage>331</fpage>
                  <lpage>342</lpage>
                  <pub-id pub-id-type="pmid">21273294</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib26">
                <label>26</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Watz</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Pitta</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Rochester</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Garcia-Aymerich</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>ZuWallack</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Troosters</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>An official European Respiratory Society statement on physical activity in COPD</article-title>
                  <source>
                    <italic>Eur Respir J</italic>
                  </source>
                  <year>2014</year>
                  <volume>44</volume>
                  <fpage>1521</fpage>
                  <lpage>1537</lpage>
                  <pub-id pub-id-type="pmid">25359358</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib27">
                <label>27</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Coultas</surname>
                      <given-names>DB</given-names>
                    </name>
                    <name>
                      <surname>Jackson</surname>
                      <given-names>BE</given-names>
                    </name>
                    <name>
                      <surname>Russo</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Peoples</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>KP</given-names>
                    </name>
                    <name>
                      <surname>Sloan</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Home-based physical activity coaching, physical activity, and health care utilization in chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease self-management activation research trial secondary outcomes</article-title>
                  <source>
                    <italic>Ann Am Thorac Soc</italic>
                  </source>
                  <year>2018</year>
                  <volume>15</volume>
                  <fpage>470</fpage>
                  <lpage>478</lpage>
                  <pub-id pub-id-type="pmid">29283670</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib28">
                <label>28</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wade</surname>
                      <given-names>DT</given-names>
                    </name>
                  </person-group>
                  <article-title>What is rehabilitation? An empirical investigation leading to an evidence-based description</article-title>
                  <source>
                    <italic>Clin Rehabil</italic>
                  </source>
                  <year>2020</year>
                  <volume>34</volume>
                  <fpage>571</fpage>
                  <lpage>583</lpage>
                  <pub-id pub-id-type="pmid">32037876</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib29">
                <label>29</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bestall</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Paul</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Garrod</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Garnham</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>PW</given-names>
                    </name>
                    <name>
                      <surname>Wedzicha</surname>
                      <given-names>JA</given-names>
                    </name>
                  </person-group>
                  <article-title>Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease</article-title>
                  <source>
                    <italic>Thorax</italic>
                  </source>
                  <year>1999</year>
                  <volume>54</volume>
                  <fpage>581</fpage>
                  <lpage>586</lpage>
                  <pub-id pub-id-type="pmid">10377201</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib30">
                <label>30</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Glasgow</surname>
                      <given-names>RE</given-names>
                    </name>
                    <name>
                      <surname>Vogt</surname>
                      <given-names>TM</given-names>
                    </name>
                    <name>
                      <surname>Boles</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluating the public health impact of health promotion interventions: the RE-AIM framework</article-title>
                  <source>
                    <italic>Am J Public Health</italic>
                  </source>
                  <year>1999</year>
                  <volume>89</volume>
                  <fpage>1322</fpage>
                  <lpage>1327</lpage>
                  <pub-id pub-id-type="pmid">10474547</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib31">
                <label>31</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ries</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Make</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Krasna</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Bartels</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Crouch</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                    <collab>National Emphysema Treatment Trial Research Group</collab>
                  </person-group>
                  <article-title>The effects of pulmonary rehabilitation in the national emphysema treatment trial</article-title>
                  <source>
                    <italic>Chest</italic>
                  </source>
                  <year>2005</year>
                  <volume>128</volume>
                  <fpage>3799</fpage>
                  <lpage>3809</lpage>
                  <pub-id pub-id-type="pmid">16354848</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib32">
                <label>32</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thom</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Willard-Grace</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Tsao</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hessler</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>DeVore</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal>
                      <italic>et al.</italic>
                    </etal>
                  </person-group>
                  <article-title>Randomized controlled trial of health coaching for vulnerable patients with chronic obstructive pulmonary disease</article-title>
                  <source>
                    <italic>Ann Am Thorac Soc</italic>
                  </source>
                  <year>2018</year>
                  <volume>15</volume>
                  <fpage>1159</fpage>
                  <lpage>1168</lpage>
                  <pub-id pub-id-type="pmid">30130430</pub-id>
                </mixed-citation>
              </ref>
              <ref id="bib33">
                <label>33</label>
                <mixed-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Conti</surname>
                      <given-names>AA</given-names>
                    </name>
                  </person-group>
                  <article-title>Historical evolution of the concept of health in Western medicine</article-title>
                  <source>
                    <italic>Acta Biomed</italic>
                  </source>
                  <year>2018</year>
                  <volume>89</volume>
                  <fpage>352</fpage>
                  <lpage>354</lpage>
                  <pub-id pub-id-type="pmid">30333455</pub-id>
                </mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
